AKT1 and endometrial cancer: In all subtypes of endometrial cancers (endometrioid and non-endometrioid tumors), the activation of the PI3K/AKT pathway is a common mechanism in contributing to epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) features [73].